Fengtian He

Army Medical University — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

44h-index5.8kcitations188works3.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Metabolism, Diabetes, and Cancer(20), RNA modifications and cancer(20), Autophagy in Disease and Therapy(17), Circular RNAs in diseases(15), Cancer Mechanisms and Therapy(15)

Publications187 total

Meta-analysis of the diagnostic value of polymerase chain reaction-based nucleic acid detection methods for pertussis
Indian Journal of Medical Microbiology·2025Open Access
Let-7i-3p inhibits the progression of gastric cancer by targeting CCND1 and suppressing the NF-κB signaling pathway
International Journal of Biological Macromolecules·2025Open Access
The oncogenic role of FOXM1 in hepatocellular carcinoma: molecular mechanisms, clinical significance, and therapeutic potentials
Naunyn-Schmiedeberg s Archives of Pharmacology·2025· 1 citedOpen Access
Corrigendum to “KIAA1429 facilitates metastasis via m6A-YTHDC1-dependent RND3 down-regulation in hepatocellular carcinoma cells” [Canc. Lett. 584 (2024) 216598]
Cancer Letters·2025
Dexamethasone Inhibits the Growth of B‐Lymphoma Cells by Downregulating <scp>DOT1L</scp>
Cancer Reports·2024Open Access
Inhibition of KIAA1429/HK1 axis enhances the sensitivity of liver cancer cells to sorafenib by regulating the Warburg effect
Biochemical Pharmacology·2024· 7 citedOpen Access
Dexamethasone inhibits the growth of B lymphoma cells by downregulating DOT1L
2024Open Access
KIAA1429 facilitates metastasis via m6A-YTHDC1-dependent RND3 down-regulation in hepatocellular carcinoma cells
Cancer Letters·2024· 22 citedOpen Access
CircPHKB decreases the sensitivity of liver cancer cells to sorafenib via miR-1234-3p/CYP2W1 axis
Genomics·2023· 5 citedOpen Access
Change and challenge: An online course in Medical Biochemistry and Molecular Biology
Biochemistry and Molecular Biology Education·2023· 4 citedOpen Access
Supplementary Figure S4 from Metformin Synergizes with BCL-XL/BCL-2 Inhibitor ABT-263 to Induce Apoptosis Specifically in p53-Defective Cancer Cells
2023Open Access
Supplementary Figure S2 from Metformin Synergizes with BCL-XL/BCL-2 Inhibitor ABT-263 to Induce Apoptosis Specifically in p53-Defective Cancer Cells
2023Open Access
Supplementary Figure 14 from Sorafenib Sensitizes (−)-Gossypol-Induced Growth Suppression in Androgen-Independent Prostate Cancer Cells via Mcl-1 Inhibition and Bak Activation
2023Open Access
Supplementary Figure S1 from Metformin Synergizes with BCL-XL/BCL-2 Inhibitor ABT-263 to Induce Apoptosis Specifically in p53-Defective Cancer Cells
2023Open Access
Data from Sorafenib Sensitizes (−)-Gossypol-Induced Growth Suppression in Androgen-Independent Prostate Cancer Cells via Mcl-1 Inhibition and Bak Activation
2023Open Access
Supplementary Figure Legend 14 from Sorafenib Sensitizes (−)-Gossypol-Induced Growth Suppression in Androgen-Independent Prostate Cancer Cells via Mcl-1 Inhibition and Bak Activation
2023Open Access
Data from Metformin Synergizes with BCL-XL/BCL-2 Inhibitor ABT-263 to Induce Apoptosis Specifically in p53-Defective Cancer Cells
2023Open Access
Supplementary Figure S2 from Metformin Synergizes with BCL-XL/BCL-2 Inhibitor ABT-263 to Induce Apoptosis Specifically in p53-Defective Cancer Cells
2023Open Access
Supplementary Figure Legends 1-13 from Sorafenib Sensitizes (−)-Gossypol-Induced Growth Suppression in Androgen-Independent Prostate Cancer Cells via Mcl-1 Inhibition and Bak Activation
2023Open Access
Supplementary Figure S1 from Metformin Synergizes with BCL-XL/BCL-2 Inhibitor ABT-263 to Induce Apoptosis Specifically in p53-Defective Cancer Cells
2023Open Access
page 1 of 10Next →

Frequent Co-authors

Gang Huang(18), Zhizhen Xu(12), Zhenhong Ni(10), Jiqin Lian(10), Yijun Zeng(10), Liang Xu(8), Xufang Dai(7), Wei Gong(7), Xinzhe Li(6), C. Hu(6), Dan Zhong(5), Haojun Xiong(5), Xilin Lyu(5), Yuanyin Zhao(5), Yaran Wu(5), Wen Xie(5), Song Li(5), Min Gao(5), Yingru Zheng(5), Annette Wilson(4)